# Enable Injections to expand manufacturing facilities and HQ in Ohio

Enable Injections plans to build a new 90,000 sq ft Manufacturing Center of Excellence in Springdale, Ohio, and enhance its corporate headquarters in Evendale, Ohio. The expansion will support clinical and commercial supply of its enFuse wearable drug delivery technology and is expected to add over 450 jobs over ten years.

- Type: Expansion
- Announced: 2024-02-14
- Where: Springdale, Ohio and Evendale, Ohio, United States
- Jobs: 450
- Starts operating: 2024
- Status: announced
- Capacity: 90,000 square feet
- Products: enFuse wearable drug delivery technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Enable Injections](https://endata.com/companies/75653.md)

## Sources

- [enableinjections.com](https://enableinjections.com/enable-injections-announces-plans-to-expand-manufacturing-facilities-and-corporate-headquarters/), 2024-02-14: "Scalable, in-house manufacturing is a key pillar of Enable’s strategy to accelerate supply of our innovative enFuse technology as the Company continues to grow our roster and scope of clinical and commercial engagements with pharmaceutical partners."
- [ohiotechnews.com](https://www.ohiotechnews.com/enable-injections-expanding-manufacturing-operations-with-new-cincinnati-area-facility/), 2024-02-22: "Scalable, in-house manufacturing is a key pillar of Enable's strategy to accelerate supply of our innovative enFuse technology"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.